is tirzepatide still being compounded Tirzepatide: Legal & Safe 2026 March 10, 2025: Patients transitioning

The results from the Boston collaborators raised questions about the physiological way that GLP-1 prompted the release of insulin, a phenomenon described as an 'insulinotropic effect' (Drucker, Philippe, Mojsov)

On the lowest dose, people taking Zepbound for weight loss lost on average 34 pounds

A single-cell transcriptomic map of the human and mouse pancreas reveals inter- and intra-cell population structure

Lead study author, Hamlet Gasoyan, DS, PhD, MPH, a researcher with Cleveland Clinics Center for Value-Based Care Research, spoke to Medical News Today , emphasizing the importance of these results in a real-world setting: Randomized clinical trials documented that discontinuation of novel obesity medications generally leads patients to regain weight, Gasoyan told us